Literature DB >> 19068402

The pathologic substrate of magnetic resonance alterations in multiple sclerosis.

Hans Lassmann1.   

Abstract

Multiple sclerosis (MS) pathology is originally defined by the presence of focal white matter lesions, characterized by inflammation, primary demyelination, and reactive glial scaring. More recently, however, it became clear that focal white matter plaques in MS comprise of a broad spectrum of different lesion types, reflecting different stages of activity and different degrees of neurodegeneration or repair. In addition, the MS brain is affected by global changes in the normal-appearing white matter and gray matter. All types of changes in the MS brain and spinal cord occur on the background of inflammation; the type of inflammation, however, differs between different stages and forms of the disease.

Entities:  

Mesh:

Year:  2008        PMID: 19068402     DOI: 10.1016/j.nic.2008.06.005

Source DB:  PubMed          Journal:  Neuroimaging Clin N Am        ISSN: 1052-5149            Impact factor:   2.264


  41 in total

1.  In vivo evidence of disseminated subpial T2* signal changes in multiple sclerosis at 7 T: a surface-based analysis.

Authors:  J Cohen-Adad; T Benner; D Greve; R P Kinkel; A Radding; B Fischl; B R Rosen; C Mainero
Journal:  Neuroimage       Date:  2011-04-13       Impact factor: 6.556

2.  Overcoming the clinical-MR imaging paradox of multiple sclerosis: MR imaging data assessed with a random forest approach.

Authors:  K Kacar; M A Rocca; M Copetti; S Sala; S Mesaros; T Stosic Opincal; D Caputo; M Absinta; J Drulovic; V S Kostic; G Comi; M Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2011-11-11       Impact factor: 3.825

3.  Brain tissue sodium concentration in multiple sclerosis: a sodium imaging study at 3 tesla.

Authors:  M Inglese; G Madelin; N Oesingmann; J S Babb; W Wu; B Stoeckel; J Herbert; G Johnson
Journal:  Brain       Date:  2010-01-27       Impact factor: 13.501

4.  Magnetic resonance monitoring of lesion evolution in multiple sclerosis.

Authors:  Alex Rovira; Cristina Auger; Juli Alonso
Journal:  Ther Adv Neurol Disord       Date:  2013-09       Impact factor: 6.570

5.  Rapid, high-resolution, whole-brain, susceptibility-based MRI of multiple sclerosis.

Authors:  P Sati; D M Thomasson; N Li; D L Pham; N M Biassou; D S Reich; J A Butman
Journal:  Mult Scler       Date:  2014-03-17       Impact factor: 6.312

6.  Ring and nodular multiple sclerosis lesions: a retrospective natural history study.

Authors:  M Davis; S Auh; M Riva; N D Richert; J A Frank; H F McFarland; F Bagnato
Journal:  Neurology       Date:  2010-03-09       Impact factor: 9.910

7.  Chronic T2 Lesions in Multiple Sclerosis are Heterogeneous Regarding Phase MR Imaging.

Authors:  S Siemonsen; K L Young; M Bester; J Sedlacik; C Heesen; J Fiehler; J-P Stellmann
Journal:  Clin Neuroradiol       Date:  2015-04-18       Impact factor: 3.649

8.  Multiple sclerosis shrinks intralesional, and enlarges extralesional, brain parenchymal veins.

Authors:  María I Gaitán; Manori P de Alwis; Pascal Sati; Govind Nair; Daniel S Reich
Journal:  Neurology       Date:  2012-12-19       Impact factor: 9.910

9.  Perivenular brain lesions in a primate multiple sclerosis model at 7-tesla magnetic resonance imaging.

Authors:  María I Gaitán; Pietro Maggi; Jillian Wohler; Emily Leibovitch; Pascal Sati; Ismael L Calandri; Hellmut Merkle; Luca Massacesi; Afonso C Silva; Steven Jacobson; Daniel S Reich
Journal:  Mult Scler       Date:  2013-06-17       Impact factor: 6.312

10.  Tissue-specific imaging is a robust methodology to differentiate in vivo T1 black holes with advanced multiple sclerosis-induced damage.

Authors:  M Riva; V N Ikonomidou; J J Ostuni; P van Gelderen; S Auh; J M Ohayon; F Tovar-Moll; N D Richert; J H Duyn; F Bagnato
Journal:  AJNR Am J Neuroradiol       Date:  2009-04-30       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.